Point of Care Diagnostics Market to Grow by 10.65% from 2022 to 2027|Abbott Laboratories, altona Diagnostics GmbH, and more to emerge as key players -Technavio

NEW YORK, July 13, 2023 /PRNewswire/ — The point-of-care diagnostics market size is estimated to grow by USD 14,645.04 million between 2022 and 2027, accelerating at a CAGR of 10.65% during the forecast period according to Technavio. The growing competition in the market is compelling vendors to adopt various growth strategies, such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market’s competitive landscape and offers information on several market vendors, including – Abbott Laboratories, altona Diagnostics GmbH, Becton Dickinson, and Co., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Meridian Bioscience Inc., Nova Biomedical Corp., Perkin Elmer Inc., QIAGEN NV, Sekisui Chemical Co. Ltd., Siemens AG, Sinocare Inc., Trinity Biotech Plc, Trivida Health Inc., and Zoetis Inc. Download The Sample Report

Why Buy?

• Add credibility to the strategy.
• Analyzes competitor’s offerings. 
• Get a holistic view of the market.
• Grow your profit margin with Technavio– Buy the Report

Point Of Care Diagnostics Market Insights –

• Vendors: 15+, Including Abbott Laboratories, Altona Diagnostics GmbH, Becton Dickinson, and Co., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Meridian Bioscience Inc., Nova Biomedical Corp., Perkin Elmer Inc., QIAGEN NV, Sekisui Chemical Co. Ltd., Siemens AG, Sinocare Inc., Trinity Biotech Plc, Trivida Health Inc., and Zoetis Inc. among others
• Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors
• Segments: Product (Hematology diagnostics, Infectious disease diagnostics, Rapid cardiovascular diagnostics, Rapid coagulation diagnostics, and Others), End-user (Hospitals and clinics, Homecare settings, and Clinical diagnostic laboratories), and Geography (North America, Europe, Asia, and Rest of World (ROW))

To understand more about the Point of Care Diagnostics market, request a sample report

Key Drivers- The growing geriatric population is one of the key factors driving market growth. People globally are suffering from various health problems that lead to serious medical problems due to a lack of physical activity and poor diet. Furthermore, as the population ages, medical expenses for physical examinations, disease diagnosis, and treatment are increasing. For instance, the elderly populations of Japan, Italy, Germany, France, Sweden, and Spain are 29%, 24%, 22%, 21%, 20%, and 20%, respectively, and are expected to grow in the coming years. Alzheimer’s disease, cardiovascular disease, bone, and joint disease, and diabetes are some of the most common health problems among older people include. These factors have increased the demand for POC diagnostic equipment among the end-users as it helps in diagnosing diseases. Hence, these factors are expected to drive market growth during the forecast period.

Major Trends- The shift from conventional testing methods to rapid diagnostics is the major trend in the market. 

Significant Challenges- Limited access to POC diagnostics in developing nations is a significant challenge restricting market growth. 

Drivers, Trends & Challenges have an impact on market dynamics and can impact businesses. Find some insights from a sample report!

The point of care diagnostics market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as prospects.

What key data is covered in this Point Of Care Diagnostics Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the point-of-care diagnostics market between 2023 and 2027
• Precise estimation of the size of the point-of-care diagnostics market and its contribution to the market with a focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the point-of-care diagnostics market across North America, Europe, Asia, and the Rest of the World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of point-of-care diagnostics market vendors

Gain instant access to 17,000+ market research reports. 

Technavio’s SUBSCRIPTION platform

Related Reports

The gas chromatography market size is estimated to grow by USD 1,042.59 million at a CAGR of 7.14% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by product (consumables, accessories, and instruments), end-user (pharmaceuticals and biotechnology, food and beverages, academic and research institutes, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The growing applications of gas chromatography is a key factor driving the market growth during the forecast period.

The cell sorting market size is estimated to grow by USD 129.02 million at a CAGR of 7.86% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by end-user (pharmaceutical and biotechnology companies, hospitals and clinical testing laboratories, and others), technology (fluorescence-based droplet cell sorting, magnetic-activated cell sorting, and micro-electromechanical systems), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The growing prevalence of chronic diseases is a key factor driving the market growth during the forecast period.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global point of care diagnostics market 2017 – 2021 
• Exhibit 18: Historic Market Size – Data Table on global point of care diagnostics market 2017 – 2021 ($ million)

• 4.2 Product Segment Analysis 2017 – 2021 
• Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)

• 4.3 End-user Segment Analysis 2017 – 2021 
• Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 – 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)

• 4.5 Country Segment Analysis 2017 – 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis – Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product – Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product – Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 Hematology diagnostics – Market size and forecast 2022-2027 
• Exhibit 34: Chart on Hematology diagnostics – Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Hematology diagnostics – Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Hematology diagnostics – Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hematology diagnostics – Year-over-year growth 2022-2027 (%)

• 6.4 Infectious disease diagnostics – Market size and forecast 2022-2027 
• Exhibit 38: Chart on Infectious disease diagnostics – Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Infectious disease diagnostics – Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Infectious disease diagnostics – Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Infectious disease diagnostics – Year-over-year growth 2022-2027 (%)

• 6.5 Rapid cardiovascular diagnostics – Market size and forecast 2022-2027 
• Exhibit 42: Chart on Rapid cardiovascular diagnostics – Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Rapid cardiovascular diagnostics – Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Rapid cardiovascular diagnostics – Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Rapid cardiovascular diagnostics – Year-over-year growth 2022-2027 (%)

• 6.6 Rapid coagulation diagnostics – Market size and forecast 2022-2027 
• Exhibit 46: Chart on Rapid coagulation diagnostics – Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Rapid coagulation diagnostics – Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Rapid coagulation diagnostics – Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Rapid coagulation diagnostics – Year-over-year growth 2022-2027 (%)

• 6.7 Others – Market size and forecast 2022-2027 
• Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
• Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)

• 6.8 Market opportunity by Product 
• Exhibit 54: Market opportunity by Product ($ million)
• Exhibit 55: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 56: Chart on End-user – Market share 2022-2027 (%)
• Exhibit 57: Data Table on End-user – Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 58: Chart on Comparison by End-user
• Exhibit 59: Data Table on Comparison by End-user

• 7.3 Hospitals and clinics – Market size and forecast 2022-2027 
• Exhibit 60: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)

• 7.4 Homecare settings – Market size and forecast 2022-2027 
• Exhibit 64: Chart on Homecare settings – Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Homecare settings – Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Homecare settings – Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Homecare settings – Year-over-year growth 2022-2027 (%)

• 7.5 Clinical diagnostic laboratories – Market size and forecast 2022-2027 
• Exhibit 68: Chart on Clinical diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Data Table on Clinical diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Chart on Clinical diagnostic laboratories – Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Clinical diagnostic laboratories – Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by End-user 
• Exhibit 72: Market opportunity by End-user ($ million)
• Exhibit 73: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 75: Chart on Market share by geography 2022-2027 (%)
• Exhibit 76: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 77: Chart on Geographic comparison
• Exhibit 78: Data Table on Geographic comparison

• 9.3 North America – Market size and forecast 2022-2027 
• Exhibit 79: Chart on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on North America – Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on North America – Year-over-year growth 2022-2027 (%)

• 9.4 Europe – Market size and forecast 2022-2027 
• Exhibit 83: Chart on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Europe – Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Europe – Year-over-year growth 2022-2027 (%)

• 9.5 Asia – Market size and forecast 2022-2027 
• Exhibit 87: Chart on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Asia – Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Asia – Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) – Market size and forecast 2022-2027 
• Exhibit 91: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)

• 9.7 US – Market size and forecast 2022-2027 
• Exhibit 95: Chart on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on US – Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on US – Year-over-year growth 2022-2027 (%)

• 9.8 Germany – Market size and forecast 2022-2027 
• Exhibit 99: Chart on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Germany – Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Germany – Year-over-year growth 2022-2027 (%)

• 9.9 UK – Market size and forecast 2022-2027 
• Exhibit 103: Chart on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on UK – Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on UK – Year-over-year growth 2022-2027 (%)

• 9.10 Canada – Market size and forecast 2022-2027 
• Exhibit 107: Chart on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on Canada – Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Canada – Year-over-year growth 2022-2027 (%)

• 9.11 China – Market size and forecast 2022-2027 
• Exhibit 111: Chart on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 112: Data Table on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 113: Chart on China – Year-over-year growth 2022-2027 (%)
• Exhibit 114: Data Table on China – Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 115: Market opportunity by geography ($ million)
• Exhibit 116: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 117: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 118: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 119: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 120: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 121: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 122: Matrix on vendor position and classification

• 12.3 Abbott Laboratories
• Exhibit 123: Abbott Laboratories – Overview
• Exhibit 124: Abbott Laboratories – Business segments
• Exhibit 125: Abbott Laboratories – Key news
• Exhibit 126: Abbott Laboratories – Key offerings
• Exhibit 127: Abbott Laboratories – Segment focus

• 12.4 altona Diagnostics GmbH
• Exhibit 128: altona Diagnostics GmbH – Overview
• Exhibit 129: altona Diagnostics GmbH – Product / Service
• Exhibit 130: altona Diagnostics GmbH – Key offerings

• 12.5 Becton Dickinson and Co.
• Exhibit 131: Becton Dickinson and Co. – Overview
• Exhibit 132: Becton Dickinson and Co. – Business segments
• Exhibit 133: Becton Dickinson and Co. – Key news
• Exhibit 134: Becton Dickinson and Co. – Key offerings
• Exhibit 135: Becton Dickinson and Co. – Segment focus

• 12.6 bioMerieux SA
• Exhibit 136: bioMerieux SA – Overview
• Exhibit 137: bioMerieux SA – Product / Service
• Exhibit 138: bioMerieux SA – Key offerings

• 12.7 Chembio Diagnostics Inc.
• Exhibit 139: Chembio Diagnostics Inc. – Overview
• Exhibit 140: Chembio Diagnostics Inc. – Product / Service
• Exhibit 141: Chembio Diagnostics Inc. – Key offerings

• 12.8 Danaher Corp.
• Exhibit 142: Danaher Corp. – Overview
• Exhibit 143: Danaher Corp. – Business segments
• Exhibit 144: Danaher Corp. – Key news
• Exhibit 145: Danaher Corp. – Key offerings
• Exhibit 146: Danaher Corp. – Segment focus

• 12.9 DiaSorin SpA
• Exhibit 147: DiaSorin SpA – Overview
• Exhibit 148: DiaSorin SpA – Business segments
• Exhibit 149: DiaSorin SpA – Key news
• Exhibit 150: DiaSorin SpA – Key offerings
• Exhibit 151: DiaSorin SpA – Segment focus

• 12.10 F. Hoffmann La Roche Ltd. 
• Exhibit 152: F. Hoffmann La Roche Ltd. – Overview
• Exhibit 153: F. Hoffmann La Roche Ltd. – Business segments
• Exhibit 154: F. Hoffmann La Roche Ltd. – Key news
• Exhibit 155: F. Hoffmann La Roche Ltd. – Key offerings
• Exhibit 156: F. Hoffmann La Roche Ltd. – Segment focus

• 12.11 Perkin Elmer Inc.
• Exhibit 157: Perkin Elmer Inc. – Overview
• Exhibit 158: Perkin Elmer Inc. – Business segments
• Exhibit 159: Perkin Elmer Inc. – Key news
• Exhibit 160: Perkin Elmer Inc. – Key offerings
• Exhibit 161: Perkin Elmer Inc. – Segment focus

• 12.12 QIAGEN NV
• Exhibit 162: QIAGEN NV – Overview
• Exhibit 163: QIAGEN NV – Product / Service
• Exhibit 164: QIAGEN NV – Key news
• Exhibit 165: QIAGEN NV – Key offerings

• 12.13 Sekisui Chemical Co. Ltd.
• Exhibit 166: Sekisui Chemical Co. Ltd. – Overview
• Exhibit 167: Sekisui Chemical Co. Ltd. – Business segments
• Exhibit 168: Sekisui Chemical Co. Ltd. – Key offerings
• Exhibit 169: Sekisui Chemical Co. Ltd. – Segment focus

• 12.14 Siemens AG
• Exhibit 170: Siemens AG – Overview
• Exhibit 171: Siemens AG – Business segments
• Exhibit 172: Siemens AG – Key news
• Exhibit 173: Siemens AG – Key offerings
• Exhibit 174: Siemens AG – Segment focus

• 12.15 Sinocare Inc.
• Exhibit 175: Sinocare Inc. – Overview
• Exhibit 176: Sinocare Inc. – Product / Service
• Exhibit 177: Sinocare Inc. – Key news
• Exhibit 178: Sinocare Inc. – Key offerings

• 12.16 Trinity Biotech Plc
• Exhibit 179: Trinity Biotech Plc – Overview
• Exhibit 180: Trinity Biotech Plc – Product / Service
• Exhibit 181: Trinity Biotech Plc – Key offerings

• 12.17 Zoetis Inc.
• Exhibit 182: Zoetis Inc. – Overview
• Exhibit 183: Zoetis Inc. – Business segments
• Exhibit 184: Zoetis Inc. – Key news
• Exhibit 185: Zoetis Inc. – Key offerings
• Exhibit 186: Zoetis Inc. – Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 187: Inclusions checklist
• Exhibit 188: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 189: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 190: Research methodology
• Exhibit 191: Validation techniques employed for market sizing
• Exhibit 192: Information sources

• 13.5 List of abbreviations
• Exhibit 193: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base comprises enterprises of all sizes, including over 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio